Blunted beta-adrenoceptor-mediated fat oxidation in overweight subjects: a role for the hormone-sensitive lipase gene.
Obesity is associated with blunted beta-adrenoceptor-mediated lipolysis and fat oxidation, which persist after weight reduction. We investigated whether dinucleotide (CA)(n) repeat polymorphisms in intron 6 (i6) or 7 (i7) and a C-60G promoter substitution of the hormone-sensitive lipase (HSL) gene are associated with a blunted in vivo beta-adrenoceptor-mediated increase in circulating fatty acids and glycerol (estimation of lipolytic response) and fat oxidation in overweight-obese subjects. A total of 103 overweight (25 kg/m(2) < or = body mass index < 30 kg/m(2)) and obese (body mass index > or =30 kg/m(2)) subjects (62 men, 41 women) were included. Energy expenditure, respiratory quotient (RQ), and circulating fatty acid and glycerol were determined after stepwise infusion of increasing doses of the nonselective beta-agonist isoprenaline. The i6, i7 (CA)(n) repeat polymorphisms were determined by size-resolved capillary electrophoresis; and a C-60G promoter substitution was determined by restriction enzyme digestion assay. Female noncarriers of allele 184 i7 (n = 18) and female carriers of allele 240 i6 (n = 12) showed an overall reduced fat oxidation (as indicated by changes in RQ) after beta-adrenoceptor-mediated stimulation, explaining, respectively, 6.9% and 20.8% of the variance in RQ. These effects were not seen in male subjects. In conclusion, our results suggest that variation in i7 and i6 of the HSL gene might be associated with a physiological effect on in vivo beta-adrenoceptor-mediated fat oxidation, at least in overweight-obese female subjects.
Jocken
Johan W E
JW
Department of Human Biology, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University, Maastricht, The Netherlands. j.jocken@hb.unimaas.nl
Blaak
Ellen E
EE
van der Kallen
Carla J H
CJ
van Baak
Marleen A
MA
Saris
Wim H M
WH
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D000483:Alleles; D001823:Body Composition / Q000502:physiology; D015992:Body Mass Index; D004247:DNA / Q000235:genetics; D004041:Dietary Fats / Q000378:metabolism*; D018900:Dinucleotide Repeats / Q000235:genetics; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D005990:Glycerol / Q000097:blood; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000235:genetics* / Q000378:metabolism*; D010084:Oxidation-Reduction; D011110:Polymorphism, Genetic / Q000235:genetics / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000235:genetics* / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D002787:Sterol Esterase / Q000235:genetics* / Q000502:physiology*
D000318:Adrenergic beta-Agonists; D004041:Dietary Fats; D005227:Fatty Acids; D011943:Receptors, Adrenergic, beta; D004247:DNA; D002787:Sterol Esterase; D007545:Isoproterenol; D005990:Glycerol